Stable Istotope Labelled Dulaglutide Biosimilar – Anti-Glucagon-like peptide-1 receptor agonist mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Istotope Labelled Dulaglutide Biosimilar - Anti-Glucagon-like peptide-1 receptor agonist mAb - Research Grade |
|---|---|
| Source | DrugBank DB09045 |
| Species | Human |
| Expression system | Mammalian cells |
| Molecular weight | 59kDa |
| Purity | >95% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue Ice |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | 4°C for short term; -20°C for long term |
| Brand | ProteoGenix |
| Aliases /Synonyms | Dulaglutide |
| Reference | PX-TA1017-SIL |
| Related Products | PX-P4732 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | hG4-Fc |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
| Formula | C2646H4044N704O836S18 |
General information about Dulaglutide
Dulaglutide is a novel glucagon-like peptide-1 agonist (GLP-1) biologic drug consisting of a dipeptidyl peptidase-IV-protected GLP-1 analogue covalently linked to a human IgG4-Fc heavy chain by a small peptide linker. Dulaglutide is indicated in the treatment of type 2 diabetes and can be used once a week. This product is for research use only.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.